Alessio Ciulli | |
|---|---|
| Born | 22 July 1977 |
| Nationality | Italian British |
| Alma mater | University of Florence(laurea), University of Cambridge(PhD) |
| Scientific career | |
| Fields | Targeted Protein Degradation, Chemical Biology |
| Institutions | University of Dundee |
| Thesis | |
| Doctoral advisors | Chris Abell |
| Website | https://www.lifesci.dundee.ac.uk/people/alessio-ciulli-0; https://www.dundee.ac.uk/cetpd |
Alessio Ciulli FRSE FRSC (born in Firenze, 22 July 1977) is an Italian British biochemist. Currently, he is the Professor of Chemical & Structural Biology at the School of Life Sciences, University of Dundee, where he founded and directs Dundee' new Centre for Targeted Protein Degradation (CeTPD). He is also the scientific co-founder and advisor of Amphista Therapeutics.[1]